The standard for this medication is the same. Do no take this medication if you are pregnant, planning to become pregnant, or breastfeeding. Do not take this medication if you have liver disease.
The potential side effects include low blood glucose or hypoglycemia, weight gain, and dizziness.
DPP-4 Inhibitor: Acronym for Dipeptidyl Peptidase-4 Inhibitor I will cover this class in a separate blog.
Sulfonylurea This is a multi-drug class and can be somewhat confusing as there are two generic only medications plus the generic names apply to several brand names. The medications are Amaryl or glimepiride, DiaBeta or glyburide, Diabinese or chlorpamide, Glucotrol or glipizide, Glucogtrol XL or glipizide long acting, Glynase or glyburide, and Micronase or glyburide. The two generic only are tolazamide and tolbutamide.
Thiazolidinedione There are two drugs is this class, Actos or pioglitazine and Avandia or rosiglitazone.
I do not want to discuss this class as one medication has been pulled from the market and the other should be. Actos has been shown to cause bladder cancer and now another study shows it raises diabetic macular edema. Read this link for all the warnings and the Food and Drug Administration advice. This is all I will say on this class.
I will cover the newest class SGLT2 Inhibitor in a separate blog.